Clinical Trials Browser

Phase 2 × Peripheral Nervous System Diseases × nicotinamide-beta-riboside × Clear all

NCT04112641 2025-07-30

NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Active not recruiting

Peripheral Nervous System Diseases